Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users

被引:40
作者
Back-Madruga, C
Boone, KB
Chang, L
Grob, CS
Lee, A
Nations, H
Poland, RE
机构
[1] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA
[2] Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA
[3] Harbor UCLA Med Ctr, Dept Neurol, Torrance, CA 90509 USA
[4] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
关键词
D O I
10.1076/clin.17.4.446.27939
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
While neuropsychological studies on 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) users have been emerging, results have been inconsistent, possibly due to methodological issues. The current study examined the performance of 22 recreational MDMA users compared to 28 age, education, and IQ comparable normal control subjects on a comprehensive battery of neuropsychological tests. Results revealed no significant differences in cognitive functioning between the MDMA users and normal controls. However, greater use of MDMA was associated with poorer scores on several measures of nonverbal memory, and greater frequency users (greater than or equal to50 times) evidenced significantly lower scores on 2 of 3 nonverbal memory tests compared to lesser frequency users (<50 times). Our results suggest that a subgroup of MDMA patients, specifically heavy MDMA users, evidence declines in nonverbal (visual) memory, however, other cognitive areas appear to be spared.
引用
收藏
页码:446 / 459
页数:14
相关论文
共 58 条
[11]   Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions [J].
Chancellor, MB ;
Chartier-Kastler, EJ .
NEUROMODULATION, 2000, 3 (01) :15-26
[12]  
Chang L, 1999, J MAGN RESON IMAGING, V10, P521, DOI 10.1002/(SICI)1522-2586(199910)10:4<521::AID-JMRI4>3.3.CO
[13]  
2-0
[14]   The relative contributions of ecstasy and cannabis to cognitive impairment [J].
Croft, RJ ;
Mackay, AJ ;
Mills, ATD ;
Gruzelier, JGH .
PSYCHOPHARMACOLOGY, 2001, 153 (03) :373-379
[15]   Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): Week-end 'high' followed by mid-week low [J].
Curran, HV ;
Travill, RA .
ADDICTION, 1997, 92 (07) :821-831
[16]   Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence [J].
Dafters, RI ;
Duffy, F ;
O'Donnell, PJ ;
Bouquet, C .
PSYCHOPHARMACOLOGY, 1999, 145 (01) :82-90
[17]  
DAFTERS RI, 1999, HUMAN PSYCHOPHARMACO, V12, P221
[18]   Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug [J].
Fox, HC ;
Parrott, AC ;
Turner, JJD .
JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (04) :273-281
[19]   No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine)users and control subjects:: A [H215O]-positron emission tomography study [J].
Gamma, A ;
Buck, A ;
Berthold, T ;
Vollenweider, FX .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (01) :66-71
[20]  
Goodglass H., 1983, BOSTON NAMING TEST